Notably, as IFN subtypes are redundant in their properties, untargeted IFN-I subtypes (which are not attacked by the hosts immune system in susceptible patients) may compensate and limit the biological consequences of IFN-I autoimmunity. The gene discussed is IFNA1; the disease is Autoimmunity.